228 related articles for article (PubMed ID: 18334832)
1. Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.
Kasper B; Dietrich S; Mechtersheimer G; Ho AD; Egerer G
Oncology; 2007; 73(1-2):58-64. PubMed ID: 18334832
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.
Kasper B; Lehnert T; Bernd L; Mechtersheimer G; Goldschmidt H; Ho AD; Egerer G
Bone Marrow Transplant; 2004 Jul; 34(1):37-41. PubMed ID: 15170176
[TBL] [Abstract][Full Text] [Related]
3. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
[TBL] [Abstract][Full Text] [Related]
4. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
Yonemoto T; Tatezaki S; Ishii T; Satoh T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1431-5. PubMed ID: 10500530
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy for pulmonary metastases of soft tissue sarcoma].
Kito M; Umeda T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195
[TBL] [Abstract][Full Text] [Related]
6. Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study.
Kasper B; Scharrenbroich I; Schmitt T; Wuchter P; Dietrich S; Ho AD; Egerer G
Bone Marrow Transplant; 2010 Jul; 45(7):1234-8. PubMed ID: 19935728
[TBL] [Abstract][Full Text] [Related]
7. [Soft tissue sarcoma: postoperative chemotherapy].
Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
[TBL] [Abstract][Full Text] [Related]
8. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
9. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
Pinkerton CR
Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
[TBL] [Abstract][Full Text] [Related]
11. [Bone sarcomas: experience of an orthopedic oncology unit in the treatment of 180 consecutive cases, 1988-1995 (Part II)].
Bickels J; Kollender Y; Nirkin A; Isakov J; Mozes M; Merimsky O; Cohen I; Ben Harush M; Noyman Y; Meller I
Harefuah; 1998 Mar; 134(5):378-81. PubMed ID: 10909556
[No Abstract] [Full Text] [Related]
12. [Evidence-based chemotherapy for patients with bone and soft part sarcoma].
Chuman H
Gan To Kagaku Ryoho; 2000 Feb; 27(2):192-202. PubMed ID: 10700889
[TBL] [Abstract][Full Text] [Related]
13. [Angiotensin II-induced hypertension chemotherapy of bone and soft-tissue sarcomas].
Tsuchiya H; Tomita K; Sugihara M; Shimizu H; Yasutake H; Morishita H; Morikawa S; Ohno M; Bunko H; Seto M
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1776-81. PubMed ID: 2543322
[TBL] [Abstract][Full Text] [Related]
14. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
15. Late effects of radiotherapy for pediatric extremity sarcomas.
Paulino AC
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):265-74. PubMed ID: 15337565
[TBL] [Abstract][Full Text] [Related]
16. Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction.
Beccheroni A; Lucarelli E; Donati D; Sangiorgi L; Capponcelli S; Gorini M; Zambon Bertoja A; Giardino R; Mercuri M; Ferrari S; Bacci G; Picci P
Oncol Rep; 2003; 10(4):891-6. PubMed ID: 12792741
[TBL] [Abstract][Full Text] [Related]
17. Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.
Reichardt P; Nielsen OS; Bauer S; Hartmann JT; Schöffski P; Christensen TB; Pink D; Daugaard S; Marreaud S; Van Glabbeke M; Blay JY;
Eur J Cancer; 2007 Apr; 43(6):1017-22. PubMed ID: 17336054
[TBL] [Abstract][Full Text] [Related]
18. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
[TBL] [Abstract][Full Text] [Related]
19. Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS).
Maurel J; Buesa J; López-Pousa A; del Muro XG; Quintana MJ; Martín J; Casado A; Martínez-Trufero J; de Las Peñas R; Balañá C
J Surg Oncol; 2004 Oct; 88(1):44-9. PubMed ID: 15384088
[TBL] [Abstract][Full Text] [Related]
20. A single institution experience of combined modality management of extra skeletal Ewings sarcoma.
Venkitaraman R; George MK; Ramanan SG; Sagar TG
World J Surg Oncol; 2007 Jan; 5():3. PubMed ID: 17217537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
